Search

Search Results

• PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri¹, Dagna Constenla², Germain Lonnet³, Emmanuel Aris³, Nathalie Servotte³, Ramsanjay Rk⁴, Agnes Mwakingwe-Omari², Huifeng Yun² | ¹GSK Verona, Italy; ²GSK Rockville, USA; ³GSK Wavre, Belgium; ⁴GSK Bengaluru, India

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2140

  176
• 

  To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis

  Alessandro Tomelleri, Christian Dejaco, Milena Bond

  13-02-2025

  https://doi.org/10.4081/reumatismo.2025.1791

  1656

  PDF: 533

• PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology Davide Rozza¹, Carlo Alberto Scirè^1|2, Paola Conigliaro³, Giacomo Emmi⁴, Laura Coladonato⁶, Salvatore Scarpato⁷, Luca Iaccarino⁸, Serena Guiducci⁹, Giulia Pazzola¹⁰, Francesca Romana Spinelli¹¹, Micol Frassi¹², Ilaria Cavazzana¹², Chiara Scirocco¹³, Valeria Orefice¹³, Immacolata Prevete¹³, Alessandra Bortoluzzi¹⁴, Marcello Govoni¹⁴, Elena Bartoloni¹⁵, Luca Moroni¹⁶, Giuseppe Alvise Ramirez¹⁶, Valentina Canti¹⁶, Giorgio Pettiti¹⁷, Maria Chiara Ditto¹⁸, Enrico Fusaro¹⁸, Marta Mosca¹⁹, Lorenzo Cavagna²⁰, Fabrizio Conti¹¹, Andrea Doria⁸, Gian Domenico Sebastiani¹³, Sperimentatori Gruppo Lire⁵ | ¹Centro Studi della Società Italiana di Reumatologia, Milano; ²Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; ³Università di Roma Tor Vergata; ⁴Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; ⁵https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; ⁶Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; ⁷Azienda Sanitaria Locale ^ASL Salerno; ⁸Università degli Studi di Padova; ⁹SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; ¹⁰Arcispedale Santa Maria Nuova Reggio Emilia; ¹¹Università degli Studi di Roma La Sapienza; ¹²Spedali Civili di Brescia; ¹³Azienda Ospedaliera San Camillo Forlanini, Roma; ¹⁴Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; ¹⁵SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; ¹⁶IRCCS Ospedale San Raffaele, Milano; ¹⁷Azienda Ospedaliera S. Croce e Carle, Cuneo; ¹⁸AOU Citta' della Salute e della Scienza di Torino; ¹⁹AOU Santa Chiara, Pisa; ²⁰Università di Pavia, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2158

  159

• PO:02:022 | Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies Fabian Proft¹, Désirée Van Der Heijde², Sergio Schwartzman^3|4|5, Joerg Ermann⁶, Alexander Marten⁷, Ute Massow⁷, George Stojan⁸, Vanessa Taieb⁹, Diana Voiniciuc¹⁰, Astrid Van Tubergen¹¹, Victoria Navarro-Compán¹², Simone Angioni¹³, Xenofon Baraliakos¹⁴ | ¹Charité-Universitätsmedizin Berlin; Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; ²Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; ³Weill Cornell Medical Center New York, USA; ⁴New York Presbyterian Hospital New York, USA; ⁵Hospital for Special Surgery New York, USA; ⁶Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School Boston, USA; ⁷UCB Monheim am Rhein Germany; ⁸UCB Atlanta, USA; ⁹UCB Colombes, France; ¹⁰UCB Slough, United Kingdom; ¹¹Department of Medicine, Division of Rheumatology, Maastricht University Medical Center Maastricht, The Netherlands; ¹²Department of Rheumatology, La Paz University Hospital, IdiPaz Madrid, Spain; ¹³UCB Milan, Italy; ¹⁴Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2285

  27

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1701

  PDF: 1086

• PO:06:083 | Clinical characteristics and outcomes of late- and young-onset rheumatoid arthritis in relation to autoantibody status Federica Sabatelli^1|2, Ludovico De Stefano^1|2, Clelia Zampaglione^1|2, Lisa Bergianti^1|2, Blerina Xoxi^1|2, Antonio Manzo^1|2, Carlomaurizio Montecucco^1|2, Serena Bugatti^1|2. | ¹Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; ²Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2015

  137

• Role of anti-prothrombin in antiphospholipid syndrome

  M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani

  243-250

  https://doi.org/10.4081/reumatismo.2002.243

  943

  PDF: 1393

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  https://doi.org/10.4081/reumatismo.2010.163

  1959

  PDF: 1330

• On the early uses of the word ‘gout’: novel evidence and a critical assessment of the published literature

  F.M. Galassi, L. Ingaliso, V. Papa, R. Lorenzi, E. Percivaldi, E. Varotto

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1704

  2166

  PDF: 1099

• PO:17:248 | Prevention of human papillomavirus infection in women with systemic lupus erythematosus: a single-center cross-sectional study Clizia Gagliardi¹, Maria Chiara Gerardi¹, Bianca Lucia Palermo¹, Giulia Carrea¹, Maria Di Cicco¹, Elena Manna¹, Giulia Segatto¹, Antonella Adinolfi¹, Laura Belloli¹, Cinzia Casu¹, Silvia Cavalli¹, Davide Antonio Filippini¹, Matteo Longhi¹, Gabriella Maioli¹, Martina Schettino¹, Nicola Ughi¹, Elisa Verduci¹, Arianna Bertolucci¹, Lara Buffa¹, Giulia Buonsante¹, Claudia Cordini¹, Eleonora Giacobbe¹, Francesco Molica Colella¹, Oscar Epis¹ | ¹ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2165

  168

• Study of vitamin D status of rheumatoid arthritis patients Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)

  B. Frediani, M. Rossini, S. Adami, G. Bianchi, O. Di Munno, L. Sinigaglia, M. Antonelli, G. Minisola

  314-318

  https://doi.org/10.4081/reumatismo.2006.314

  1655

  PDF: 2225

• Enzymes and muscle diseases

  M. Plebani

  158-165

  https://doi.org/10.4081/reumatismo.2001.158

  1490

  PDF: 3106

• PO:31:161 | First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: clinical associations from the SPRING-SIR registry Antonio Tonutti^1|2, Francesca Motta^1|2, Rossella De Angelis³, Valeria Riccieri⁴, Silvia Laura Bosello⁵, Fabio Cacciapaglia⁶, Veronica Codullo⁷, Giacomo De Luca⁸, Francesca Ingegnoli⁹, Dilia Giuggioli¹⁰, Clodoveo Ferri¹⁰, Marco Matucci-Cerinic⁸, Carlo Selmi^1|2, Maria De Santis^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³Università Politecnica delle Marche Ancona, Italy; ⁴Università degli Studi di Roma La Sapienza Roma, Italy; ⁵Università Cattolica del Sacro Cuore Roma, Italy; ⁶Università degli Studi di Bari Aldo Moro Bari, Italy; ⁷Reumatologia, Fondazione IRCCS Policlinico San Matteo Pavia, Italy; ⁸Università Vita-Salute San Raffaele Milano, Italy; ⁹Università degli Studi di Milano, Italy; ¹⁰Università degli Studi di Modena e Reggio Emilia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2366

  47
• 

  Trends in severe outcomes in SARS-CoV-2-positive hospitalized patients with rheumatic diseases: a monocentric observational and case-control study in northern Italy

  N. Ughi, D.P. Bernasconi, C. Gagliardi, F. Del Gaudio, A. Dicuonzo, A. Maloberti, C. Giannattasio, C. Rossetti, M.G. Valsecchi, O.M. Epis

  17-07-2023

  https://doi.org/10.4081/reumatismo.2023.1542

  1211

  PDF: 569

  SUPPLEMENTARY FILE: 141

• Osteoporosis and diabetes

  L.J. Dominguez, M. Muratore, E. Quarta, G. Zagone, M. Barbagallo

  235-241

  https://doi.org/10.4081/reumatismo.2004.235

  3912

  PDF: 2230

• PO:36:243 | Drug survival, discontinuation reasons and disease activity in patients with Behçet's disease treated with infliximab - a real-life study Antonello Sulis¹, Federica Di Cianni¹, Maria Laura Manca², Rosaria Talarico¹, Marta Mosca¹. | ¹Rheumatology Unit of Pisa, University of Pisa, Pisa, Italy, Pisa, Italy; ²Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa, Italy, Pisa, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2091

  161

• PO:02:030 | Retention Rate of Non-anti-TNF Therapies and primary failure in monocentric cohort of patients with Psoriatic Arthritis Alba Chiara Pozzi¹, Sofia Barezzani², Andrea Galli², Cesare Tomasi¹, Micol Frassi¹, Ilaria Cavazzana¹, Franco Franceschini¹ | ¹Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, University of Brescia Brescia, Italy; ²Facoltà di Medicina e Chirurgia, University of Brescia Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2288

  24

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  https://doi.org/10.4081/reumatismo.2001.40

  1192

  PDF: 1103

• PO:31:168 | Risk factors for cancer in systemic sclerosis, impact on disease phenotype and prognosis, and proposal of machine learning-based personalized screening strategies: insights from an EUSTAR study Antonio Tonutti^1|2, Francesca Motta^1|2, Stefano Erba^1|2, Britta Maurer³, Cristiana Sieiro Santos³, Duygu Temiz Karadag³, Elena Rezus³, Elisabetta Zanatta³, Fabiola Atzeni³, Francesco Benvenuti³, Gabor Kumanovics³, Gabriella Szucs³, Gianluca Moroncini³, Gonçalo Boleto³, Leila Caillault³, Lilian Maria Lopez Nunez³, Masataka Kuwana³, Massimiliano Limonta³, Maurizio Cutolo³, Oliver Distler³, Radim Bevcar³, Roberto Giacomelli³, Rossella De Angelis³, Serena Guiducci³, Stefano Stano³, Valeria Riccieri³, Yasser El Miedany³, Sophie Blaise³, Carlo Selmi^1|2, Maria De Santis^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³EUSTAR collaborators EUSTAR * OTHER

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2367

  26

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  https://doi.org/10.4081/reumatismo.2009.132

  2152

  PDF: 1213